Support our global clinical development programs providing scientifically and technically sound expertise in tissue-based biomarker analysis for therapeutic candidates from oncology, immuno-oncology, immunology.
You will help advancing innovative technologies, especially our digital pathology platform based on single and/or multiplex IHC/IF/ISH methods. Also, contribute to understand relevant tissue-based mode-of-action and predictive biomarkers for companion diagnostic development.
The selected candidate will act as biomarker expert representing our ‘Integrative & Exploratory Pathology,’ group internally and externally.
Who you are:
Bachelor’s degree with 8 plus years of experience, Master’s degree with 3 plus years of experience, or PhD degree required
A minimum of 3 years of pharma, biotech, and/or CRO experience strongly preferred
Working experience in tissue-based biomarkers in clinical development (single and/or multiplex IHC/IF/ISH platforms, histopathology, digital pathology).
Good understanding of biomarkers strategies, operations, and quality requirements in clinical development.
Track record of publications in oncology, immunology, clinical/translational biomarker research strongly preferred